Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
go back to main search page
Accession:CHEBI:114242 term browser browse the term
Definition:An oxadiazole that has formula C23H26N4O2.
Synonyms:related_synonym: Formula=C23H26N4O2;   InChI=1S/C23H26N4O2/c1-17-6-8-19(9-7-17)23-25-22(29-26-23)11-10-21(28)24-13-15-27-14-12-18-4-2-3-5-20(18)16-27/h2-9H,10-16H2,1H3,(H,24,28);   InChIKey=ZWRRCMRKCLGPSK-UHFFFAOYSA-N;   SMILES=CC1=CC=C(C=C1)C2=NOC(=N2)CCC(=O)NCCN3CCC4=CC=CC=C4C3
 xref: LINCS:LSM-25703


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 227
    chemical entity 227
      molecular entity 227
        polyatomic entity 219
          molecule 205
            cyclic compound 186
              ring assembly 3
                N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 227
    subatomic particle 227
      composite particle 227
        hadron 227
          baryon 227
            nucleon 227
              atomic nucleus 227
                atom 227
                  main group element atom 220
                    p-block element atom 220
                      carbon group element atom 208
                        carbon atom 207
                          organic molecular entity 207
                            organic molecule 202
                              organic cyclic compound 186
                                organic heterocyclic compound 144
                                  organic heteromonocyclic compound 96
                                    oxadiazole 0
                                      N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.